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Induction of manganese superoxide dismutase by glucocorticoids In
glomerular cells. Our previous in vivo study demonstrated that methyl-
prednisolone (MP) activates glomerular antioxidant enzymes and atten-
uates glomerular oxidant injuries, including those in experimental
nephrosis. The present study investigates the cellular mechanism of the
MP-induced activation of antioxidant enzymes and their contribution to
the attenuation of cellular oxidant toxicity. When bovine glomerular
endotheial cells (GECs) were treated with 10 sM MP, cellular manga-
nese superoxide dismutase (Mn-SOD, 3.95 0.33 Jmg protein, M
SE) and catalase (1.64 0.06 k/mg protein) activities were significantly
(P < 0.05) elevated above control GECs (2.23 0.43 img protein and
1.06 0.09 k/mg protein, respectively). When GECs pretreated with
MP (10 &M 24 hrs) were exposed to xanthine (0.1 mM) + xanthine
oxidase (5 mU/ml) for four hours, levels of specific membrane lipid
peroxidation products, that is, phosphatidylcholine- and phosphati-
dylethanolamine-hydroperoxides, remained at levels 10 to 25% of those
measured in non-MP-treated (xanthine/xanthine oxidase-exposed) con-
trol cells. Moreover, the degree of cell damage following exposure to
the superoxide generating system, assessed by 51Cr release, was
significantly attenuated in MP-treated cells (50% of MP-non-treated
controls, N = 6). Thus, MP-treated GECs with elevated antioxidant
enzyme activities by MP were more resistant to the toxic effect of
reactive oxygen metabolites. The mechanism of antioxidant enzyme
induction by MP was studied for Mn-SOD. MP was shown to enhance
Mn-SOD mRNA in bovine GECs and rat glomerular mesangial cells
(GMCs) in dose-dependent manners. The transcriptional activation of
the Mn-SOD gene by MP was studied using a luciferase reporter gene
containing a 1.2 kb fragment (—806 to +406 bp of the transcription
initiation site) of rat Mn-SOD genomic DNA. GMCs transfected with
the fusion gene construct demonstrated a significant increase (2.6-fold)
in luciferase activity when treated with 10 M MP. Therefore, the
induction of Mn-SOD by MP involves transcriptional activation. Re-
suits with the fusion gene study predict the existence of a functional
glucocorticoid responsive element(s) within the 1.2 kb fragment of the
Mn-SOD gene DNA.
It is well established in prokaryotic cells that manganese
superoxide dismutase (Mn-SOD), a mitochondnal antioxidant
enzyme, is tightly regulated to meet their biological needs, that
is, to defend them from the toxic oxidants produced in their
environment [1, 2]. The biological significance of Mn-SOD has
been increasingly recognized in eukaryotic cells in a number of
settings [3—5]. For example, a protective effect of induction of
renal Mn-SOD was shown in a study with transgenic mice
carrying excessive Mn-SOD genes. Morphologic analysis of the
kidney following experimental transient ischemia/reperfusion in
these mice revealed a distinctive pattern of tissue protection
from injury [6].
Glucocorticoids constitute the first-line of treatment of ne-
phrotic syndrome and are remarkably effective in treating
minimal change nephrotic syndrome [7]. However, the way in
which this treatment brings remission to nephrosis is still a
mystery. Particularly puzzling is the fact that glucocorticoids
are therapeutically effective in the animal model of nephrosis
(puromycin aminonucleoside nephrosis), while, unlike its hu-
man counterpart, this animal model lacks evidence of T cell
activation through which glucocorticoids potentially work [8].
In this regard, a novel hypothesis has recently been postulated
based on the results of a series of animal studies suggesting that
the therapeutic effect of steroids is modulated through their
capacity to upregulate renal antioxidant enzymes, especially
Mn-SOD. First, as in the lung [9, 10], renal Mn-SOD is
inducible by methylprednisolone. Glomeruli isolated from rats
given a daily injection of methylprednisolone were found to
have significantly higher activities of antioxidant enzymes,
especially that of Mn-SOD, than those from untreated rats [11].
Moreover, glomeruli of these animals were shown to develop
remarkable tolerance to diverse modes of oxidant stress. De-
pletion of Mn-SOD by administration of diethyldithiocarbamate
leads to aggravation of PAN nephrosis in rats [12], while
experimental supplementation of SOD ameliorates the typical
functional and morphologic abnormalities of the glomerulus
[13].
Given the ubiquitous nature of the glucocorticoid receptors
present in tissues, it remains to be determined whether gluco-
corticoids have a capacity to induce renal antioxidants locally.
The present in vitro studies investigate this potential regulatory
effect of glucocorticoids on Mn-SOD in glomerular cells and its
functional significance, and they attempt to delineate some of
the key mechanisms involved in this regulation.
Methods
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Materials
Cell culture media, Hanks balanced salt solutions, fetal
bovine serum, penicillin/streptomycin, and amphotericin B
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were purchased from GIBCO (Grand Island, New York, USA);
Nu serum from Collaborative Research Inc. (Bedford, Massa-
chusetts, USA); 1.1 '-dictadecyl-3,3,3',3'-tetramethyl-indocarbo-
cyanine perchiorate (Dil-Ac-LDL) from Biochemical Technolo-
gies (Stoughton, Massachusetts, USA); EDTA, formaldehyde
from Fisher; diethyl pyrocarbonate (DEPC) from Fluka Chemika
(Buchs, Switzerland); agarose (free RNase), restriction enzymes,
tuciferase reporter gene (pGL2-Promoter vector) and 3-galactosi-
dase reporter gene from Promega (Madison, Wisconsin, USA);
methylprednisolone from Upjohn (Kalamazoo, Michigan, USA);
51chromium (Cr), and [32P]ATP from New England Nuclear
(Boston, Massachusetts, USA). All other reagents were pur-
chased from Sigma (St. Louis, Missouri, USA).
Glomerular endothelial cell culture
Glomerular endothelial cell culture was established as previ-
ously described with a minor modification [14]. Briefly, fresh
young calf kidneys were purchased from a local slaughterhouse
(Tennessee Dressed Beef, Nashville, Tennessee, USA). Ap-
proximately 20 g of the cortex was excised, minced, and passed
through autoclaved 180 and 140 m sieves. Glomeruli on the
surface of the 140 m sieve were washed with HBSS and
collected in a 50 ml centrifuge tube. This glomerular preparation
was routinely >98% pure, and 80 to 85% of glomeruli were free
of Bowman's capsules. Glomeruli were then washed three
times by centrifugation and resuspended in HBSS. Glomeruli
were then incubated for 15 to 20 minutes at 37°C in I mg/ml
collagenase in HBSS buffered with 20 mivt HEPES and then
washed and suspended in a RPM! 1640 medium containing 17%
FBS, 2% Nu serum, 5 U/mi penicillin, 5 g/ml streptomycin,
and 0.25 pg/mi amphotericin B (endothelial cell medium) at
37°C in 5% CO2 and 95% air. When colonies that morphologi-
cally resembled glomerular endothelial cells appeared, individ-
ual clones were isolated with cloning cylinders. For subculture,
cells were plated into gelatin-fibronectin coated plates with a
RPMI 1640/14% FBS. Cells from passages between 5 and 16
were used for the subsequent experiments. Each clone of cells
was identified as endothelial by expression of factor VIII and
endocytosis of acetylated low density lipoprotein (LDL) [14].
Glomerular mesangial cell culture
Rat glomerular mesangial cell culture was established as
previously described [15]. Briefly, kidneys were excised from
male Sprague-Dawley rats weighing 100 to 150g. Cortical tissue
was minced and passed through a series of stainless steel sieves
of decreasing pore size: 180, 106, and 75 M. The fraction
accumulating on the 75 m sieve was collected in HBSS
buffered with 20 mre Hepes followed by three washes. The
glomeruli were treated with collagenase (1 mg/mI) and then
plated onto 100-mm (P100) plastic tissue culture plates main-
tained in RPM! 1640 supplemented with 17% FBS, penicillin
100 s/ml, streptomycin 100 g/ml, and fungizone 0.25 g/ml at
37°C in 5% CO2 and 95% air.
When mesangial cells were propagated, they were subcul-
tured using trypsin/EDTA. The cells were characterized by
their shapes and immunochemical staining of actin. Passages
between S and 18 were used in the experiments. The cells were
maintained in RPM! 1640 with 14% FBS medium all the time
except during the transfection of plasmids as specified below.
Measurement of antioxidant enzyme activities
Cellular antioxidant enzyme activities were examined in ceth
treated with methylprednisolone. Near confluent cells on P10(
plates were incubated with medium containing 10 M methyl.
prednisolone for 2 to 24 hours. Control cells were incubatec
with fresh medium for 0 to 24 hours. At the end of incubation,
plates were washed three times with ice-cold phosphate buff
ered saline (PBS), removed from plates by a rubber policeman,
and suspended in 1 ml per plate of PBS. Cells from three P10(
plates were combined into one tube to obtain a sufficieni
amount of sample for the subsequent assays. Cell suspensiom
were sonicated (Output power 7, 5 sec x 3 times, W-22
Sonicator, Heat Systems-ultrasonics, Inc., Farmingdale, Ne
York, USA) and centrifuged (800 g, 15 mm, 4°C), and the
supernatants were immediately frozen and stored at —70°C untii
assay.
Activities of superoxide dismutases (SODs), catalase, and
glutathione peroxidase (GSH-Px) were measured as previously
described. Briefly, SOD activities were assayed based on the
cytochrome c auto-oxidation method by McCord and Fridovicli
[16, 17]. Cyanide uninhibitable activity was regarded as Mn-
SOD activity by adding 1 mrr potassium cyanide in a reaction
mixture, whereas total SOD was determined by the reaction
mixture with low cyanide concentration (10 ILM) [17], and
Cu/Zn-SOD activity was calculated by total minus Mn-SOIJ
activity. The amount of SOD required to inhibit the rate ol
reduction of cytochrome c by 50% was defined as 1 unit ol
activity. Catalase activity was measured using the method ol
Aebi [18]. The rate constant of a first order reaction (k) was
used as a unit. GSH-Px activity was measured by the method of
Beutler et al [19], which uses an oxidation reaction of reduced
glutathione by glutathione peroxidase coupled to the disappear-
ance of NADPH by glutathione reductase using tertbutyl hy-
droperoxide as the substrate. The activity was calculated using
the extinction coefficient of NADPH at 340 nm, 6.22 mM'
cm'.
Assessment of oxidant-induced cellular injury
A superoxide anion generation system was used to examine
whether methylprednisolone alters the susceptibility of cells to
oxidant stress. In this experiment, one group of glomerular
endothelial cells (on P60 plates) was treated with 10 M
methylprednisolone for 24 hours, and the other group of cells
underwent exchange of medium with no methylprednisolone.
Following 24 hours of incubation, cells were exposed to xan-
thine (100 M) and xanthine oxidase (5 mU/ml) for four hours.
Some cells were exposed to xanthine only to serve as a
time-control. Assessment of cellular injury was determined by
two methods, measurements of lipid peroxidation products and
51Cr release, as described below.
As a specific index of oxidant stress, membrane lipid perox-
idation products, phosphatidyicholine hydroperoxide (PC-
OOH) and phosphatidylethanolamine hydroperoxide (PE-
OOH), were measured after exposure to xanthine oxidase
and/or xanthine. In this experiment, cells were washed twice
with ice cold PBS with 5 mst EDTA and removed from the plate
by a rubber policeman. Cell suspensions were centrifuged
(1,000 g, 5 mm) and resuspended in 2 ml of PBS with 0.5 M
EDTA. Lipids were extracted by methanol and chloroform, and
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the lipid extracts were assayed for PC- and PE-OOH by
chemiluminescent HPLC as previously described [20, 211.
Values were corrected for the number of cells counted by a
Coulter counter. 51Cr release by endothelial cells following
oxidant stress was used as a general index of cellular injury [22].
Cultured cells were prelabeled with 3 sCiIml or 10 tCiIml 51Cr
for four hours, washed three times with HBSS, and exposed to
xanthine oxidase and/or xanthine for four hours. Subsequently,
cells were washed three times with HBSS, and associated and
released chromium was counted by a gammacounter (LKB 1250
Compugamma, Turku, Finland).
mRNA expression study
To examine whether methylprednisolone alters gene expres-
sion of Mn-SOD in glomerular cells, Northern blot analysis was
performed using bovine glomerular endothelial and rat mesan-
gial cells. Rat mesangial cells were included because: (1)
homologous probes for both Mn- and Cu/Zn-SOD were avail-
able; and (2) a subsequent reporter gene study for gene tran-
scription was possible only for rat genomic Mn-SOD DNA. In
this study, near confluent cells on P100 plates were incubated
with 0.1, 1, or 10 /LM methylprednisolone for 2 to 24 hours in an
identical manner to the above-described study of enzyme
activities. Control cells were incubated with medium without
methylprednisolone. After the completion of incubation, cells
were washed twice with ice-cold PBS, and total RNA was
isolated by the guanidinium thiocyanate/phenol method as
previously described [23]. The obtained RNA pellet was
washed with 75% ethanol, centrifuged (1,400 g, 10 mm), dried,
and dissolved in DEPC-treated water. The concentration of
RNA was estimated by absorption at 260 nm, and the samples
were stored at —70°C until the assay.
For Northern blot analysis, 20 pg of total RNA was dena-
tured in 25 jil of formamide, formaldehyde, MOPS, pH 7.0,
sodium acetate, EDTA, and ethidium bromide at 65°C for 10
minutes. The RNA was electrophoresed on a 1% agarose, 6%
formaldehyde MOPS buffer gel [24], transferred to a non-
charged nylon membrane (Genescreen, Dupont, Albany, Mas-
sachusetts, USA), and covalently cross-linked to the membrane
with UV light [25]. The membrane was then hybridized (16 to 18
hours, 65°C) with a 32P-labeled cDNA of bovine Mn-SOD
eDNA (for glomerular endothelial cells), rat Mn-SOD cDNA
and Cu/Zn-SOD cDNA (for glomerular mesangial cells), and
human f3-actin cDNA (Clontech, Palo Alto, California, USA).
The full length eDNA for bovine Mn-SOD (1.3 kb) had been
previously isolated and characterized by us [26]. Rat Mn-SOD
cDNA (1.6 kb) and Cu/Zn-SOD cDNA (0.6 kb) had been
previously isolated and sequenced and were kindly provided to
us by Dr. Nick of University of Florida [24]. The cDNA probes
were labeled by a random primer extension method (Bethesda
Research Laboratory, Gaithersberg, Maryland, USA). Follow-
ing hybridization, the membranes were washed in 0.04 M
sodium phosphate in 1% SDS at 65°C (30 mm, 3 times) and
subjected to autoradiography using an intensifying screen at
—70°C (1 to 4 days). The blots obtained were semiquantitated
by densitometry using Bio-Rad video densitometry Model 620
(Hercules, California, USA).
Analysis of transcriptional activity using a fusion gene of the
rat Mn-SOD regulatory region and a luciferase reporter gene
To evaluate the transcriptional control of the Mn-SOD gene
by methyiprednisolone, a fusion gene construct containing a
luciferase expression vector and a fragment of the rat Mn-SOD
genomic DNA regulatory region was constructed based on the
recently published genomic sequence by Ho, Howard and Crapo
[5]. The genomic Mn-SOD DNA fragment was obtained by PCR
amplification of the rat genomic DNA from a Sprague-Dawley rat
liver. Thus, based on the genomic sequence previously published,
primers for PCR (TGGAGAATFCAGTGGCAGAGGAAAGC-
TGC for sense and AGGTGAATFCGTGGTACTFCTCCTCG-
GTG for antisense) were prepared, and a 1.2 kb fragment of the rat
Mn-SOD genomic segment (—806 to +408 bp of the transcription
initiation site) was amplified with Taq DNA polymerase using a
thermal cycler (VFCIOO, MI Research, Inc., Watertown, Massa-
chusetts, USA) with 1.5 minutes initializing at 94°C, followed by
30 cycles of 35 seconds at 95°C (melting), 35 seconds at 63°C
(annealing), and three mm at 72°C (primer extension), finally
terminating with seven minutes at 72°C. The obtained amplified
DNA fragment was directly cloned into a pCRH® cloning vector
(Invitrogen, San Diego, California, USA), and the nucleotide
sequence of the fragment was verified using a sequence kit
(Sequenase, U.S. Biochem. Corp., Cleveland, Ohio, USA). The
fragment was then excised with restriction enzymes, Sac I and
Xho I, and ligated into pGL2-Promoter (pGL2P) vector (Promega)
(pGL2P —806: +408).
Mesangial cells were transfected with the fusion gene to
evaluate transcriptional activation by methylprednisolone.
Transfection was performed using the calcium phosphate
method [27]. Briefly, 10 jsg per P60-dish of test plasmid (pGL2P
or fusion gene) and 10 pg of pSV /3-galactosidase (pSV I3GAL)
were dissolved in 256 d of 0. lx TE, pH 8 (1 mt Tris Cl, pH 8,
0.1 mM EDTA) with 250 mt CaCl2, and mixed with an equal
volume of 2 x Hepes-buffered saline (20 m NaCl, 10 mi KC1,
1.5 mM Na2HPO4, 12 m Dextrose, and 50 ms Hepes) for 30
minutes at room temperature. The pSV /3GAL contained both
SV4O early promoter and an enhancer, and cellular /3-galacto-
sidase activity was used as an index of transfection efficiency.
Cells were plated on P60 dishes at 72 hours before the trans-
fection, and the medium was replaced from RPMI 1640/14%
FBS to DMEM-F12/l0% FBS at 12 to 16 hours before. Before
the transfection, the medium was washed and cells were
incubated with CMFH for 15 minutes. The CMFH was then
replaced with the calcium phosphate solution containing plas-
mid and incubated for 30 minutes in an incubator, after which a
3 ml solution of DMEM-F12/10% FBS was added. Five hours
after transfection, cells were shocked with 10% glycerol in
HBSS, and the medium was replaced with the regular culture
medium (RPMI/14% FBS).
Forty-eight hours after transfection, cells were treated with
methylprednisolone. Twenty-four hours (in some cells, 2 to 12
hours) after the treatment, cells were harvested and lysed in 55
mM Tris-phosphate, pH 7.8, 2 ifiM DTF, 2 m'vi 1,2-diaminocy-
clohexane-N,N,N',N'-tetraacetic acid, 10% glycerol, and 1%
Triton X-l00; cellular extracts were stored at —70°C until
assayed for protein concentration, luciferase, and /3 galactosi-
dase activities.
Protein concentration of cellular extract was determined by
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Fig. 1. Enzyme activities of Cu/Zn-, Mn-
superoxide dismutase (SOD), catalase, and
glutathione peroxidase (GSH-PX) in
glomerular endothelial cells (GECs). GECs
were cultured in P100 plates and treated with
10 1.LM methyiprednisolone (MP) or medium
only (control) for 24 hours. The activities of
antioxidant enzymes were expressed per mg
of cellular protein, * P < 0.05.
the bicinchoninic acid method previously described [28]. Fifty
micrograms of cellular protein were used for each luciferase and
13-galactosidase assay. Luciferase activity was determined by
luminescence produced by luciferase using coenzyme A as a
substrate by a luminometer (Model ILA911, Tropix, Bedford,
Ma). Our pilot study demonstrated that photon emission by this
reaction is stable for at least five seconds to two minutes after
the initiation of reaction. A linear relationship between standard
luciferase and relative light unit of the luminometer was ob-
tained between 10_16 and 10—12 M. /3-galactosidase activity was
determined spectrophotometrically using o-nitropheny1-3-D-ga-
lactopyranoside as a substrate [29]. To minimize the variability
due to the difference in transfection efficiency among plates, the
activity of luciferase from each sample was corrected based on
the activity of /3-galactosidase, as previously described [30].
Statistics
All values are expressed as the mean SE. Data from two
groups were compared by unpaired i-test. Data from multiple
groups were compared by one way analysis of variance with a
Scheffe's F-test [31]. P < 0.05 was considered to be statistically
significant.
Results
Effect of methyiprednisolone on antioxidant enzyme activities
in glomerular endoihelial cells
Superoxide dismutases (SODs), catalase, and glutathione
peroxidase (GSH-Px) activities in cultured glomerular endothe
hal cells are shown in Figure 1. Activities of cyanide-unin-
hibitable or Mn-SOD and catalase were significantly higher in
glomerular endothelial cells treated with 10 jM methyipred-
nisolone for 24 hours compared to those incubated with medium
alone. Activities of cyanide-inhibitable SODs (Cu/Zn-SOD) and
GSH-Px in methyiprednisolone-treated glomerular endothelial
cells were not statistically different from untreated control cells.
The time course of the methylprednisolone-induced changes
in Mn-SOD activity in glomerular endothelial cells is shown in
Figure 2. Mn-SOD activity was similar to baseline at two hours
(2.12 0.24 and 2.23 0.30 p1mg prot for 2 hr and baseline,
respectively). It was significantly elevated at six hours (2.79
0.22 p/mg prot) and was further elevated at 12 and 24 hours
(3.68 0.33 and 3.95 0.43 p1mg protein, respectively).
Functional signjficance of methyiprednisolone-induced
elevation in antioxidant enzyme activities
To investigate the functional significance of elevated antiox-
idant enzyme levels, methyiprednisolone-treated glomerular
endothelial cells were exposed to oxidant stress, and parame-
ters of cellular injury were evaluated. Both methyipredniso-
lone-treated (10 M, 24 hr) and -untreated cells (control, me-
dium only, 24 hr) were exposed to xanthine and xanthirte
oxidase for four hours.
As shown in Figure 3, xanthine and xanthine oxidase treat-
ment resulted in marked and significant elevation in the param-
eters of specific membrane lipid peroxidation products, that is,
PC- and PE-OOH in control glomerular endothelial cells. Com-
pared to glomerular endotheial cells not exposed to oxidant
stress (those treated with xanthine alone), the levels of these
phospholipid hydroperoxides were four times higher. In con-
trast, methyiprednisolone-treated cells exposed to xanthine and
Cu/Zn SOD
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xanthine oxidase remained similar to baseline values of PC- and
PE-OOH. Another parameter of cell injury, namely, 51Cr re-
lease, was measured in separate sets of glomerular endothelial
cells. As shown in Figure 4, change in 51Cr release following
xanthine and xanthine oxidase treatment was significantly at-
tenuated in cells treated with methylprednisolone. Therefore,
the cells treated with methylprednisolone exhibited a greater
resistance to oxidant-induced lipid peroxidation and cellular
damage.
Effect of methyiprednisolone treatment in Mn-SOD mRNA
expression
To examine whether methylprednisolone-induced enhance-
ment of Mn-SOD activity involves induction of Mn-SOD
mRNA, Northern blot analysis was performed using total
RNAs isolated from bovine glomerular endothelial cells (Fig.
5A). Experiments were also performed in rat mesangial cells
(Fig. SB). As shown in Figure 5A, glomerular endothelial cells
treated with 1,0 and 10 /.M methylprednisolone showed en-
hanced expression of Mn-SOD mRNA (hybridized with bovine
cDNA) compared to control and those treated with 0.1 M
methyiprednisolone. In bovine, Mn-SOD mRNA exhibits three
cisforms of 3.4, 1.7, and 1.4 kb [26]. Expression of /3-actin
mRNA was not altered by treatment with methylprednisolone.
For rat mesangial cell mRNA expression, the effects of meth-
ylprednisolone were essentially similar to those observed in
endothelial cells. In rat tissue and cells, including mesangial
cells, it has been shown that Mn-SOD mRNA consists of three
to five bands (depending upon the intensity of expression) [24,
25]. Semi-quantitation of changes in the density of Mn-SOD
revealed that the mesangial cells treated with 0.1, 1.0, and 10
/SM had 1.2 0.1-fold, 3.5 0.2-fold, and 6.6 0.1-fold
increases, respectively, compared to the untreated control cells
(Fig. 6). Mn-SOD iuRNA expression in mesangial cells was
enhanced when they were treated with 1 and 10 jsM methyl-
prednisolone. Expressions of Cu/Zn-SOD and /3-actin mRNAs
in mesangial cells were unaffected by the treatment. Densito-
metric analysis showed that cells treated with 10 /LM methyl-
prednisolone had 8.5 2.0-fold increase for Mn-SOD but no
increase (1.2 0.2-fold increase) for Cu/Zn-SOD.
Transcriptional activity of Mn-SOD fusion gene construct
Increases in Mn-SOD mRNA expressions in methylpred-
msolone-treated endothelial and mesangial cells appeared indic-
ative of transcriptional activation by methyiprednisolone.
Therefore, a direct analysis of transcriptional activity of the
Mn-SOD gene was performed using a luciferase reporter gene.
As shown in Table 1, methyiprednisolone-treated mesangial
cells transfected with an expression vector containing a lu-
ciferase reporter gene and the 1.2 kb fragment of Mn-SOD
genomic DNA (—806 to +408 of transcription initiation site)
demonstrated a significant increase in transcriptional activity
upon exposure to 10 /LM methylprednisolone. In contrast, cells
transfected with pGL2P, that is, without the Mn-SOD DNA
fragment failed to show appreciable changes in transcriptional
activity by methyiprednisolone treatment.
Discussion
In designing the present study, we set three experimental
goals, namely: (1) to ascertain whether the capacity of methyl-
prednisolone to induce glomerular antioxidant enzymes, dem-
onstrated in an earlier in vivo study [11], can be attributed to a
local effect on specific glomerular cells rather than to a second-
ary or systemic effect and, if 50, (2) to determine whether the
degree of 'local induction' is sufficient to confer protection to
cells when exposed to oxidants. Also, in view of the paucity of
data regarding the mechanism of Mn-SOD regulation in mam-
malian cells, we aimed (3) to delineate some of the key
mechanisms involved in the glucocorticoid-dependent Mn-SOD
regulation of glomerular cells.
At the onset of this work, only the bovine (and not other
mammalian) Mn-SOD cDNA sequence was available to us [26].
Also, the methodology for only bovine [14], (but not rat)
glomerular endothelial cell culture had been established. For
these reasons, we chose to carry out our study using the
primary bovine glomerular endothelial cell culture. The rat
Mn-SOD genomic DNA sequence subsequently became avail-
able [5]. The sequence analysis of the rat gene identified the
basic arrangement of exons and introns on the rat Mn-SOD
gene, thereby enabling us to test the responsiveness to gluco-
corticoids of the cis-transcriptional control elements of this
gene. Based on our observation that glucocorticoids increase
Mn-SOD mRNA in both bovine endothelial cells and rat me-
sangial cells, we performed our study on the glucocorticoid-
dependent transcriptional regulation of the rat mesangial cell.
In our first set of studies, Mn-SOD and catalase activities, but
not Cu/Zn-SOD or glutathione peroxidase activities, were
found to increase significantly in response to 10 jsM methylpred-
nisolone. The concentration has been shown to induce a variety
of enzymes in in vitro cell preparations through specific glu-
cocorticoid receptors [32, 33]. The observed contrasting pat-
terns in responsiveness between Mn-SOD and Cu/Zn-SOD
duplicate our earlier in vivo observation [11] and echo the
notion established for eukaryotic cells that Mn-SOD is induc-
ible, whereas Cu/Zn-SOD is largely constitutive [24, 25].
In the present study, the functional significance of the ob-
served antioxidant enzyme induction was verified by imposing
oxidant stress exogenously on methylprednisolone-pretreated
Mn-SOD activity
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Fig. 2. Time course of changes in Mn-SOD activity in GECs. GECs
were incubated with 10 ILM of methyiprednisolone (MP, hatched bars)
or with medium only (open bars) for 2 to 24 hours, and the activity was
measured from cell extracts. * P < 0.05 vs. control 0 hr.
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cells. Assessments of specific lipid peroxidation products and
cell viability measured by 51Cr release collectively indicate that
these methyiprednisolone-treated cells were resistant to lipid
peroxidation and cell damage upon exposure to oxidants. In the
present study, however, not only Mn-SOD but also catalase and
potentially other unmeasured antioxidant enzymes were acti-
vated as well. Thus, the observed acquisition of resistance to
oxidants may not be attributable solely to the effect on Mn-SOD
of glucocorticoids. In this regard, persuasive evidence for the
functional significance of Mn-SOD induction per se is available
in a recent study by Wispd et al [34] in a model of a transgenic
mouse carrying excess Mn-SOD genes. The pulmonary epithe-
hal cells from this transgenic mouse which exhibited increased
levels of Mn-SOD (similar to those found in the present study)
were shown to be more tolerant of the toxic effect of oxygen.
Likewise, Wong et al [35] demonstrated that the induction of
Mn-SOD by TNF-a in human embryonic kidney cells was
blocked by transfecting cells with antisense Mn-SOD cDNA
and that the increased cellular resistance to the cytotoxic effect
of oxidants which was otherwise demonstrable in TNF-a-
treated cells was markedly compromised. These qualitative
analyses on other mammalian cell preparations constitute rea-
sonable bases on which to speculate that the Mn-SOD induction
achieved in glomerular cells by glucocorticoids in the present
study is also a functionally significant one.
Up-regulation of Mn-SOD mRNA by methyiprednisolone
was demonstrated in endothelial as well as in mesangial cells.
Nevertheless, not all cell types respond to glucocorticoids. For
example, when rat glomerular epithelial cells and bovine pul-
monary endothelial cells were treated with 10 or 50 sMmeth-
ylprednisolone, there was no detectable induction of Mn-SOD
mRNA (Yoshioka, Meyrick et al, unpublished observations).
Moreover, in a primary culture of hepatocyte, dexámethasone
did not induce Mn-SOD mRNA [25]. However, a synergistic
increase in Mn-SOD mRNA expression was found when those
cells were tEeated with IL-6 and dexamethasone. These findings
suggest cell specific regulation of the Mn-SOD gene by gluco-
corticóids. This by no means implies that the benefit of the
Mn-SOD induction is confined to the specific cell types in which
the gene can be activated by glucocorticoids. For example,
neutrophils and other circulating cells [361, as well as resident
glomerular cells (most notably mesangial cells) [37], are capable
of producing toxic levels of oxidants under pathologic condi-
tions. Mn-SOD induction in these infiltrating cells may protect
other adjacent cells, such as epithelial cells, from oxidant
stress. Of interest in this context is the recent preliminary
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Fig. 3. Lipid hydroperoxide levels in GECs
exposed to the superoxide generation system,
GECs were pretreated with 10 sM
methyiprednisolone (MP) or medium only
(control) for 24 hours. Cells were then
exposed to xanthine (100 sM) and xanthine
oxidase (5 mU/mi) for 4 hours. Some cells
were exposed to xanthine only (N = 6).
Following the treatment, cellular lipid extracts
were assayed for phosphatidyl choline
hydroperoxide (PC-OOH) and
phosphatidylethanolamine hydroperoxide(PE-OOH), markers for specific membrane
lipid peroxidation, by HPLC. The levels
(mean SE) in cells not exposed to a
superoxide generation system, that is, those
treated with xanthine only, are given as
horizontal stripes in the figure. * P < 0.05 vs.
control cells.Control MP
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Fig. 4. 5tCr release in GECs exposed to a superoxlde generation
system. GECs were pretreated with 10 sM methylprednisolóne (MP) or
medium änly (control) for 24 hours. The cells were then prelabeled with
3 CiIml 51Cr for 4 hours, followed by treatment with xanthine oxidase
(XO) and/or xanthine identical to that in Figure 3. Cell-associated and
-dissociated activities of 51Cr were counted, and the difference in
released 51Cr between XO-treated (superoxide generated) and un-
treated (control) cells was calculated. * p < 0.05.
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Fig. 5. Northern analysis of SOD mRNA expressions in bovine gb-
merular endothelial cells (A) and rat glomerular mesangial cells (B).
Cells grown in P100 dishes were treated with 0.1 to 10 M methylpred-
nisolone for 24 hours. Control cells were incubated with the same
medium only (RPMI 1640/14% FBS) for the same period. Twenty
micrograms of total RNA extracted from cells were electrophoresed,
transferred to a nylon membrane, and hybridized with bovine Mn-SOD
cDNA (bottom) and with human /3-actin (top) for GECs (A); rat
Mn-SOD cDNA (bottom), rat Cu/Zn-SOD (middle), and f3-actin (top)
for mesangial cells (B). Mn-SOD mRNAs consisted of several bands
ranging from 1.3 kb to 4.2 kb, as previously described [24, 25]. A.
Induction of Mn-SOD mRNA was observed in the endothelial cells
treated with 1 or 10 LM methyiprednisolone, MP (lanes 3 and 4,
respectively), compared to control cells (lane 1), whereas the expres-
sion was low and comparable to control in those treated with 0.1 M MP
(lane 2). The expression of /3-actin was not altered by MP. B. Similar to
endothelial cells, induction of Mn-SOD mRNA was observed in mesan-
gial cells treated with 1 or 10 sM methylprednisolone, MP (lanes 3 and
4, respectively), compared to control cells (lane 1), whereas the
expression was low and comparable to control in those treated with 0.1
ILM MP (lane 2). The expressions of /3-actin and Cu/Zn-SOD were not
altered by MP.
Methyiprednisolone concentration, iM
Fig. 6. Densitometric analysis of bovine Mn-SOD mRNA expression in
bovine gbomerular endothelial cells treated with 0.1, 1.0, and 10 sc
methyiprednisobone. Densities of SOD mRNAs in the autoradiograph
were semiquantitated with a densitometer. Obtained densities were
corrected for those of /3-actin and compared with control cells of the
same autoradiograph (that is, same membrane). Ratio to the average
values of untreated cells (fold-increase) was then calculated. Values are
mean SE. N = 5.
report by Macconi et al [38] showing that the neutrophils
harvested from nephritic patients with antineutrophil cytoplas-
mic autoantibody-positive vasculitis produced abnormally high
levels of superoxide which could be normalized by pulse
methylprednisolone therapy. Mn-SOD mRNA was substan-
tially unregulated in neutrophils from the methyiprednisolone-
treated patients. The investigators speculated that the Suppres-
sion of oxidants released from the neutrophils by
glucocorticoids may be pivotal to their therapeutic effect on the
microvasculature.
Table 1. Transcriptional activity of Mn-SOD gene assessed by a
luciferase reporter gene in glomerular mesangial cells treated with
methylprednisolone
Plasmid N
Relative change
to control
pGL2P —806: +408 5 2.60 O2&'
pGL2P 5 1.06 0.l2a
Cultured rat glomerular mesangial cells were transfected with 10 sg
of a luciferase reporter gene which contains SV4O early promoter
(pGL2P) and pGL2P linked with the —806: +408 fragment of a rat
Mn-SOD DNA. The cells were cotransfected with 10 sg of plasmid
expressing /3-galactosidase as a control for transfection efficiency.
Forty-eight hours after the transfection, cells were treated with 10 tM
methyiprednisolone for 24 hours; luciferase activity of cellular extract
was then determined.
a Ratio of luciferase activity in methylprednisolone-treated cells to
average values of activity in respective control cellsb p < 0.05 vs. pGL2P
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Finally, we investigated the effect of glucocorticoids on the
transcription of the Mn-SOD gene in mesangial cells. The result
showed that patterns of transcriptional activation assessed by
luciferase activity parallel those of Mn-SOD induction mea-
sured at the mRNA level. It was further noted that this
up-regulatory effect of glucocorticoids on transcriptional activ-
ity is dose-related. The activation of gene transcription by
glucocorticoids is widely known to involve binding of the
hormone-receptor complex to a consensus sequence ('glucocor-
ticoid responsive element' or GRE) within the cis-transcrip-
tional control elements of the gene. OREs may be located in the
intron or the exons outside the coding region [33]. In general,
GREs are made up of 15 bp core sequences, comprised of two
halves of 5 or 6 bp interrupted by a few central base pairs of
random sequence [33, 39]. One half of the hexanucleotide is
preserved in divergent species [33, 39]. Such hexanucleotides
are found in the rat genomic Mn-SOD DNA at —30 to —25 bp
(TGTCCT) and at +38 to +43 (TGFCT) of the transcription
initiation site, both of which are included in the 1.2 kb fragment
tested in our reporter gene assay. The latter is located at an
untranslated region of the gene and has structural characteris-
tics of a typical GRE, with another conserved sequence
(GAACG) separated by 3 bp from TGTTCT. It is reasonable to
speculate, therefore, that the transcriptional activation by glu-
cocorticoids of the 1.2 kb Mn-SOD DNA fragment is attribut-
able to either or both of these elements. A series of deletion
mutation studies is obviously required to determine whether
these specific fragments indeed function as GREs.
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